Rovin Capital Oncolytics Biotech Inc Transaction History
Rovin Capital
- $361 Million
- Q3 2025
A detailed history of Rovin Capital transactions in Oncolytics Biotech Inc stock. As of the latest transaction made, Rovin Capital holds 20,620 shares of ONCY stock, worth $21,651. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,620
Previous 20,620
-0.0%
Holding current value
$21,651
Previous $16,000
81.25%
% of portfolio
0.01%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ONCY
# of Institutions
58Shares Held
2.82MCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY383KShares$402,5130.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il382KShares$401,1530.0% of portfolio
-
Marshall Wace, LLP London, X0324KShares$340,1810.0% of portfolio
-
Seeds Investor LLC New York, NY258KShares$271,2210.08% of portfolio
-
Goldman Sachs Group Inc New York, NY209KShares$219,1320.0% of portfolio
About ONCOLYTICS BIOTECH INC
- Ticker ONCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 57,867,400
- Market Cap $60.8M
- Description
- Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...